Blogs

Categories

Select a Sub-Category

Films and Coatings
Pharmaceutical Packaging Components
Prefillable Systems
Self Injection Devices
Vial Containment Solutions
Washing and Sterilization
Reconstitution and Transfer Devices

Select a Sub-Category

Analytical Lab Services
Contract Manufacturing
Fill-Finish
Regulatory Support

Select a Sub-Category

Cell and Gene Therapy Packaging
Drug Development Process
Regulatory Challenges
Transitioning to Combination Products

Select a Sub-Category

Corporate Development
ESG/Sustainability
One West Team (Employee Culture)
Our Culture of Giving (Philanthropy)
Research and Development

Previous Blogs

Integrated Solutions Program Graph
Customer Experience Drug Development Integrated Solutions Knowledge Center
Introducing West’s New Interactive Integrated Solutions Webpage

By Shari Krusniak

九月 11, 2020

West is pleased to announce the launch of our newly designed Integrated Solutions interactive webpage. After months of hard work and dedication, we are delighted to offer this dynamic page to help deliver insightful and meaningful content to our customers with an improved user experience.

Read More
SmartDose in use.
SmartDose Drug Delivery Platform Drug Development Market Traction
How the FDA PFDD initiative is bringing the patients voice earlier into drug development

By Victoria Morgan

八月 14, 2020

In the biologics space, there are clear trends toward higher delivery volumes, less frequent dosing, and the conversion from intravenous to subcutaneous delivery. This is driving demand for wearable technologies. Read more below about the FDA’s Patient-Focused Drug Development (PFDD) Initiative and how these findings can enable more insightful patient offerings.

Read More
Compounding Pharmacy drug products
Combination Product Drug Development
Injectable Combination Product Development: Facilitating Risk-Based Assessments for Efficiency and Patient Centric Outcomes

By Fran DeGrazio

五月 01, 2020

The environment for developing an injectable drug device combination product (CP) is dynamic from a regulatory and technical perspective. At the center of it all are the patients and their needs. West is pleased to announce the publication of its review manuscript that provides a detailed overview of best practices for this kind of development program. It considers technical and regulatory aspects and can be used as a foundational document for drug formulators, scientists and engineers working in this area.

Read More